This HTML5 document contains 181 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://dx.doi.org/10.3945/
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q35677262
rdf:type
wikibase:Item
schema:description
2011年論文 ৭ ডিসেম্বর ২০১১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artículo científico publicado en 2011 vitenskapelig artikkel 2011年论文 wissenschaftlicher Artikel scientific article published on 7 December 2011 2011年論文 videnskabelig artikel мақолаи илмӣ artikulong pang-agham bilimsel makale tieteellinen artikkeli 2011年论文 научна статия artykuł naukowy scientific article published on 7 December 2011 artikel ilmiah مقالة علمية نشرت في 7 ديسمبر 2011 artigo científico 2011年論文 teaduslik artikkel scienca artikolo artigo científico tudományos cikk wetenschappelijk artikel 2011年论文 scientific article published on 7 December 2011 2011年の論文 мақолаи илмӣ article científic 2011年論文 artikull shkencor article scientifique επιστημονικό άρθρο 2011年论文 научни чланак articolo scientifico vetenskaplig artikel artículu científicu espublizáu en 2011 vědecký článek 2011 nî lūn-bûn artigo científico bài báo khoa học articol științific სამეცნიერო სტატია 2011년 논문 2011年论文 научная статья vedecký článok գիտական հոդված מאמר מדעי mokslinis straipsnis article scientific vitskapeleg artikkel 2011年论文 научни чланак наукова стаття, опублікована в грудні 2011 2011年論文 บทความทางวิทยาศาสตร์ naučni članak
p:P577
wds:Q35677262-A3924588-05BF-4947-9654-C131B47CE5F8
wdt:P577
2011-12-07T00:00:00Z
p:P407
wds:Q35677262-EEF8B7D3-4AC4-45A6-AA44-7369CE94C124
wdt:P407
wd:Q1860
p:P2860
wds:Q35677262-397D59C2-F558-440B-9FB2-2425FB0FF46E wds:Q35677262-41BDD916-0063-4829-99C4-A8B23C5314EC wds:Q35677262-4CE15BCC-9B1F-497B-B229-5F3B44B6D6D7 wds:Q35677262-0A8A3E0E-5BCE-48FD-B4EB-1D2BD603730A wds:Q35677262-1C2416F0-A7C8-4D1B-AC40-655DB56AC200 wds:Q35677262-2B92E817-3290-474F-8C1F-B496D986095F wds:Q35677262-07A89CB8-5868-4360-99FC-F1A65A89AB4A wds:Q35677262-A1B1FC31-F152-4E49-B0CE-0C4F6F2D5C3C wds:Q35677262-7B15708F-8393-4EFE-8C00-07389402AAFA wds:Q35677262-90692FD8-CFDC-40A7-82D2-55E77205262B wds:Q35677262-9628B722-3F9E-4EBE-BA6B-71C93FA064B5 wds:Q35677262-6E652BF3-BE2A-4BF8-ADA2-41895E1EDF95 wds:Q35677262-6EEABC00-8E5F-4BD6-8DE1-EC81D3582D42 wds:Q35677262-6F63441B-AEFA-4403-BF8D-98BF28CB24A1 wds:Q35677262-712173B1-EA7D-45EE-9B52-1BE9EDE7B469 wds:Q35677262-6B48B140-B517-4307-9C3E-3C1DB000ED0C wds:Q35677262-C58C5AB4-498D-43BA-B6D8-707E432FC735 wds:Q35677262-C72CFE6F-5B52-4705-B8F9-C3365DE64A7E wds:Q35677262-CC9AC5D5-2051-4999-B8F0-A08F0D4BA1B6 wds:Q35677262-BAD366F1-153B-47AE-9F89-288DA8081A4C wds:Q35677262-AA0E44C4-1B05-46CB-B606-E4679B89C130 wds:Q35677262-ADAFA474-7EA1-466B-BF9D-1A2026E1AB29 wds:Q35677262-A264724B-54CF-4F36-94D7-9A9FBDD8A0EA wds:Q35677262-A548D3FC-D2C0-485C-90D7-7828C0ABFEDD wds:Q35677262-F0709CAD-954D-423B-9CE5-C0CFE9F92274 wds:Q35677262-F39BBCE6-B052-4D44-B7E2-E63CD1480239 wds:Q35677262-F5E34094-2C0B-458D-906B-1F641A90F102 wds:Q35677262-E0C9D472-0092-4292-9E9E-FB3B84542775 wds:Q35677262-D19B4428-40BE-4C97-8B66-5FBE6AACE8E4 wds:Q35677262-D47CF871-78F4-4D2D-8595-15DF1E07A69E wds:Q35677262-D861D1BC-F19E-4645-AF6F-7CB724ECE63A
wdt:P2860
wd:Q24241212 wd:Q34595288 wd:Q83630465 wd:Q36682671 wd:Q29547759 wd:Q79795239 wd:Q22250892 wd:Q79961571 wd:Q35060170 wd:Q44666271 wd:Q36340671 wd:Q34711194 wd:Q34425055 wd:Q43991032 wd:Q35006662 wd:Q29615122 wd:Q44477346 wd:Q47381748 wd:Q33889352 wd:Q36830624 wd:Q46599891 wd:Q34659858 wd:Q28186874 wd:Q56774146 wd:Q33888248 wd:Q30399340 wd:Q29547283 wd:Q83350957 wd:Q48575894 wd:Q37807515 wd:Q29619465
p:P2093
wds:Q35677262-E7906352-75F8-4E0D-AA98-09CB3BDD8C96 wds:Q35677262-DE7E52E8-CE4A-4D6B-A420-367C9D866D83 wds:Q35677262-C0A2A6FC-8396-4469-8F3F-9A580958C065 wds:Q35677262-C210CC6A-53D6-4AF1-9233-3010FBD2672C wds:Q35677262-B79A5D20-0A5C-41AE-96F3-87DADCC054DE wds:Q35677262-A0B4DE43-3B8A-4E88-921D-B8112D4A914F wds:Q35677262-319E6E2B-8507-4DF1-B6A2-C1FFD0DE7B7C
wdt:P2093
Michelle Look Michael Schwiers Charles H Bowden Wesley W Day Kishore M Gadde Craig A Peterson W Timothy Garvey
rdfs:label
Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
skos:prefLabel
Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
schema:name
Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
p:P50
wds:Q35677262-589E4291-C0BE-4530-A43B-1377983B11A1 wds:Q35677262-6275E6C8-A8FA-4799-AA07-45E29DCEDC55
wdt:P50
wd:Q37368139 wd:Q5230948
p:P1476
wds:Q35677262-07771223-C16E-440C-9B6A-23B65947FF06
wdt:P1476
Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
p:P304
wds:Q35677262-A83F8CFC-7969-410B-BEEC-3E0CF9E5147B
wdt:P304
297-308
p:P31
wds:Q35677262-09330454-F530-4396-B206-09BCAA87AF2C
wdt:P31
wd:Q13442814
p:P921
wds:Q35677262-679C3BC4-EF7B-46EE-A009-C48D16165ED7 wds:Q35677262-967AF265-3207-4965-9B24-096831FD46DD
wdt:P921
wd:Q269829 wd:Q12174
p:P698
wds:Q35677262-BB1785B4-9F28-437F-B860-4CF88DFF4089
wdtn:P698
n12:22158731
wdt:P698
22158731
p:P1433
wds:Q35677262-B562E32E-53E3-4FD7-8A4A-3380406C62BF
wdt:P1433
wd:Q7713500
p:P433
wds:Q35677262-98385856-C7A2-4079-92C7-5C66D81B5043
p:P478
wds:Q35677262-DE768806-3C4A-4D99-A997-C375F703BDB7
wdt:P433
2
wdt:P478
95
p:P356
wds:Q35677262-FC7D6316-C294-402D-B862-2B192EFDC4CB
wdtn:P356
n10:AJCN.111.024927
wdt:P356
10.3945/AJCN.111.024927
p:P5875
wds:Q35677262-7C486E92-5055-49A2-98C3-A3A6A7744042
wdt:P5875
51868697
p:P932
wds:Q35677262-CF24DF68-76B0-4B61-B266-DFDFC540784D
wdt:P932
3260065